EUVIMEDEUVIMED entdecken
Open Access

Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness

Juan Long, Hong-Wei Zuo

World Journal of Diabetes · 15.06.2025 · 16 (6)

DOI: 10.4239/wjd.v16.i6.99602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Diabetes, online erschienen am 15.06.2025. Verfasst von Juan Long und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Changsha Chang Hao Hospital, Changsha 201102, Hunan Province, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Managing sudden deafness (SD) in patients with diabetes mellitus (DM) is particularly challenging due to the heightened risk of adverse effects associated with systemic drug administration. This study explores the potential of retroauricular subperiosteal injection as a localized drug delivery method for a more effective and safe treatment. AIM To compare the efficacy of retroauricular subperiosteal injection vs systemic intravenous glucocorticoid (GC) administration for SD in patients with DM and assess the effects on blood glucose levels. METHODS A total of 128 cases of type 2 DM (T2DM) with SD diagnosed and treated in Zibo Central Hospital from February 2021 to July 2023 were divided into two groups: An observation group (66 cases receiving retroauricular subperiosteal injection of methylprednisolone) and a control group (62 cases receiving systemic intravenous administration of methylprednisolone). The two groups were compared in terms of therapeutic efficacy, hearing recovery, blood glucose level changes, and incidence of adverse reactions. Binary logistic regression was used to analyze the factors affecting therapeutic efficacy. RESULTS The observation group showed a significantly higher total effective rate (90.91%) compared with the control group (75.81%, P < 0.05). Additionally, pure-tone hearing threshold, fasting plasma glucose, and 2-hour postprandial blood glucose were significantly lower in the observation group compared with the control group (P < 0.05). The incidence of adverse reactions was also lower in the observation group than in the control group (7.58% vs 22.58%, P < 0.05). A T2DM course longer than 5 years and systemic intravenous GC administration were identified as independent risk factors for treatment inefficacy (P < 0.05). CONCLUSION In treating patients with diabetes and SD, retroauricular subperiosteal injection of methylprednisolone offers superior therapeutic efficacy and lower incidence of adverse reactions compared with systemic intravenous GC administration, with minimal impact on blood glucose.

Schlagwörter

Stichwörter der Autor:innen

Glucocorticoid delivery methodsGlucose metabolismHearing recoveryLocal steroid therapyRetroauricular subperiosteal injectionSudden deafnessSystemic intravenous administrationType 2 diabetes management

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Changsha Chang Hao Hospital, Changsha 201102, Hunan Province, China.
  • Department of Otolaryngology, Head and Neck Surgery, Zibo Central Hospital, Zibo 255000, Shandong Province, China. 18765690762@163.com.

Zitieren

APA

Long, J., & Zuo, H. W. (2025). Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness. World Journal of Diabetes, 16(6). https://doi.org/10.4239/wjd.v16.i6.99602

Vancouver

Long J, Zuo HW. Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness. World Journal of Diabetes. 2025;16(6). doi:10.4239/wjd.v16.i6.99602

BibTeX
@article{Long2025,
  author = {Long, Juan and Zuo, Hong-Wei},
  title = {Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness},
  journal = {World Journal of Diabetes},
  year = {2025},
  volume = {16},
  number = {6},
  doi = {10.4239/wjd.v16.i6.99602}
}
Kostenlos starten →